Urban Supreme System

ps: Dear book friends, this book will be finished tomorrow. Thank you for your continued support.

The next day, reports about Yijia Medicine came in overwhelmingly. ┝╪.《﹝. c［o

Most of these reports were commissioned by Zheng Pharmaceutical Group and tried their best to beautify Ningjia Medicine.

Therefore, some reports describe Ningjia medicine as unique and life-saving medicine, as if the emergence of Ningjia medicine is the savior of all mankind.

However, there are also some reports that seek truth from facts, neither belittling Nijia medicine nor overly promoting it.

One of the reports mentioned patients with hepatitis C, and its title was: "Ningjia medicine, or sky-high-priced medicine? Life-saving medicine, or money-stealing medicine?"

This report very truly pointed out the various advantages and disadvantages of Ningjia medicine. There is no denying that Ningjia medicine is indeed a good medicine. The cure rate can reach 90%, which is indeed incomparable with similar drugs.

However, if you choose Yijia medicine for treatment, one course of treatment will cost more than 500,000 yuan, which is difficult for patients to accept.

Therefore, this report calls on Zheng's Pharmaceutical Group to lower the price of Yijia medicine.

However, Zheng's Pharmaceutical Group did not express any response at all, and did not even respond. Obviously, it is impossible to change the selling price.

Many evaluation agencies have made predictions, and they all believe that the sales revenue of Yijia Pharmaceutical in the first year may reach more than 100 billion yuan, and the sales revenue in the second year can exceed 200 billion yuan. w［ww.．

As long as there are no drugs of the same level on the market, Ningjia Medicine can achieve this sales revenue.

This sales revenue may seem unbelievable, but considering that there are so many hepatitis C patients around the world, and the price of the Ningjia drug is so high, this sales revenue is still very likely to be achieved, and it can even be said to be underestimated.

The estimates made by the evaluation agency have caused the shares of Zheng Pharmaceutical Group to continue to rise, and its market value has increased from US$30 billion to more than US$35 billion.

It can be said that this news will undoubtedly benefit Zheng Pharmaceutical Group a lot. He also gave them a shot in the arm.

The annual sales revenue exceeds 100 billion, which is of great significance to a pharmaceutical company.

so. In this way, Zheng's Pharmaceutical Group is even less likely to lower the price of Yijia Medicine. They will definitely stick to this pricing.

It's basically impossible to change.

Not only will Zheng's Pharmaceutical Group not change the selling price, it will also go on sale in advance. In two days, it will be fully stocked and sold.

Originally, Su Zhe thought that Changhua Pharmaceutical would launch a new drug soon, giving Zheng Pharmaceutical Group a blow and making them unhappy.

Because Changhua Pharmaceutical has already made all the preparations for the new drug to be launched on the market, all human clinical trials have been successfully completed, and the formalities for applying for marketing have basically been completed. ┞┡╪w{ww.．

But now at the last step, it got stuck. The Food and Drug Administration has not yet agreed to let the new drug go on the market.

normally. This process has been completed, and the last step is the easiest, and it won't take long to pass.

After all, Changhua Pharmaceutical is not a small pharmaceutical company. It has enough strength to develop a new drug. The most important thing is that Changhua Pharmaceutical has completed all the procedures and the clinical trials are very successful. There are no problems with this new drug at all.

According to this situation, there will generally be no problems with the launch of new drugs, but now it is stuck at the last moment. New drugs cannot be put on the market.

When Su Zhe learned the news from Li Changhua, he was very angry.

Because he knew very well what was going on. It must be something dirty done by some people, and someone must be putting pressure on the Food and Drug Administration. Or make some small moves to prevent the new drug from passing smoothly and deliberately delay the approval time.

Needless to say, this matter was most likely done by the Zheng family, and there should be no doubt about it.

However, apart from the fact that it has not yet passed the approval in China, there are many countries that have passed the approval. Already allowing new drugs to be sold in their countries.

The reason why foreign approvals are so efficient is because Changhua Pharmaceutical has now cooperated with many countries. There are people who are easy to handle, so the approvals are much faster.

The most important thing is that Su Zhe had already put forward a condition when selling the body-building pill.

If other countries want to purchase health pills, they must open up the market to allow Changhua Pharmaceutical's drugs to enter smoothly, and cannot deliberately set up obstacles.

Therefore, Changhua Pharmaceutical's new drugs are approved faster abroad than domestically, and they are already ready for sale.

Li Changhua asked: "What should we do now? Should we hold a press conference?"

Su Zhe said without hesitation: "Okay, the new drug press conference will be held as normal. Don't stop all work. In short, let the general public know that we have launched new drugs, so that they will not rush to buy Ningjia drugs."

Now he is no longer angry and has new plans in his mind.

Su Zhe had expected the new medicine to be blocked, but he had never thought that the other party would use such a dirty and low-end method, which was why he was so angry.

However, now that he has calmed down, he is no longer so angry.

Since the Zheng family wants to play, Su Zhe will play with them to see who can outplay whom.

Therefore, on the day when Zheng's Pharmaceutical Group's new drug was launched, Changhua Pharmaceutical also held a new drug press conference to promote its new drug.

The biggest difference between the press conferences of Zheng's Pharmaceutical and Changhua Pharmaceutical is that Zheng's Pharmaceutical invites reporters to attend the press conference, while reporters apply for the press conference of Changhua Pharmaceutical.

One was invited and the other was applied. The difference between the two reflects the media's attitude towards them.

After all, every time Changhua Pharmaceutical launches a new drug, it brings great shock to the pharmaceutical industry, and every time is no exception, so the major media pay special attention to Changhua Pharmaceutical.

Moreover, the new drug launched by Changhua Pharmaceutical this time is the same kind of drug as the new drug launched by Zheng Pharmaceutical Group.

Thanks to the publicity of Yijia Pharmaceutical, the new medicine launched by Changhua Pharmaceutical has attracted more attention this time.

Therefore, the media will take the initiative to apply for a quota to attend Changhua Pharmaceutical's new drug launch conference. This is a very normal phenomenon.

This time, the host of the new drug press conference was still Li Changhua, but Su Zhe still did not show up and was still sitting in the audience.

At the beginning of the press conference, Li Changhua publicized the name, uses and therapeutic effects of the new drug.

This new drug is called Lianjia Medicine. Its main purpose is the same as that of Yijia Medicine, but its treatment range is wider and it can treat more diseases.

As for the therapeutic effect, let alone that.

The cure rate of Yijia medicine reaches 90%, which is already a very high number.

However, the cure rate of Lianjia Medicine is over 99%, which can basically be said to be 100%. (To be continued.)

...

... ()